Literature DB >> 24838676

Pharmacoeconomic advantages of oral minocycline for the therapy of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs).

B A Cunha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24838676     DOI： 10.1007/s10096-014-2113-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  22 in total

Review 1.  Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement.

Authors:  Ann L N Chapman; R Andrew Seaton; Mike A Cooper; Sara Hedderwick; Vicky Goodall; Corienne Reed; Frances Sanderson; Dilip Nathwani
Journal:  J Antimicrob Chemother       Date:  2012-01-31       Impact factor: 5.790

2.  Cephalexin remains the preferred antibiotic for uncomplicated cellulitis: revisited.

Authors:  Burke A Cunha
Journal:  J Chemother       Date:  2014-02-18       Impact factor: 1.714

3.  Economic evaluation of treatment for MRSA complicated skin and soft tissue infections in Glasgow hospitals.

Authors:  R A Seaton; S Johal; J E Coia; N Reid; S Cooper; B L Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-08-31       Impact factor: 3.267

4.  Oral antibiotic treatment of MRSA infections.

Authors:  B A Cunha
Journal:  J Hosp Infect       Date:  2005-05       Impact factor: 3.926

5.  Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.

Authors:  Peggy S McKinnon; Sonja V Sorensen; Larry Z Liu; Kamal Mf Itani
Journal:  Ann Pharmacother       Date:  2006-05-23       Impact factor: 3.154

6.  Oral and i.v.-to-p.o. switch antibiotic therapy of hospitalized patients with serious infections.

Authors:  Burke A Cunha
Journal:  Scand J Infect Dis       Date:  2008

Review 7.  Minocycline, often forgotten but preferred to trimethoprim-sulfamethoxazole or doxycycline for the treatment of community-acquired meticillin-resistant Staphylococcus aureus skin and soft-tissue infections.

Authors:  Burke A Cunha
Journal:  Int J Antimicrob Agents       Date:  2013-09-13       Impact factor: 5.283

Review 8.  A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice.

Authors:  M Dryden; A T Andrasevic; M Bassetti; E Bouza; J Chastre; G Cornaglia; S Esposito; G French; H Giamarellou; I C Gyssens; D Nathwani; S Unal; A Voss
Journal:  Clin Microbiol Infect       Date:  2010-03       Impact factor: 8.067

9.  Bacterial endocarditis on a prosthetic valve. Oral treatment with amoxicillin.

Authors:  M Lidji; E Rubinstein; H Samra
Journal:  Chest       Date:  1978-08       Impact factor: 9.410

Review 10.  Problems arising in antimicrobial therapy due to false susceptibility testing.

Authors:  B A Cunha
Journal:  J Chemother       Date:  1997-05       Impact factor: 1.714
View more
  2 in total

Review 1.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

Review 2.  Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.

Authors:  Nicholas W Carris; Joe Pardo; Jose Montero; Kristy M Shaeer
Journal:  Open Forum Infect Dis       Date:  2015-11-25       Impact factor: 3.835
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.